financetom
Business
financetom
/
Business
/
Brazil meatpacker JBS to spend $100 million to build 2 factories in Vietnam
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazil meatpacker JBS to spend $100 million to build 2 factories in Vietnam
Mar 29, 2025 12:45 PM

By Patricia Vilas Boas

(Reuters) - Brazilian meatpacker JBS announced on Saturday that it will invest US$100 million to build two factories in Vietnam, aiming to expand its presence in Southeast Asia and strengthen its position in the global market.

According to a statement from the company, the plants will produce beef, pork and poultry, and will mainly use raw materials imported from Brazil. The goal is to supply Vietnam and other countries in the region.

The agreement was formalized on Saturday through a memorandum of understanding with the Vietnamese government, JBS said. Reuters reported last week that JBS was considering the deal.

The deal was sealed during a state visit by Brazilian President Luiz Inácio Lula da Silva to Vietnam, in which the opening of the Vietnamese market to Brazilian meat was announced. JBS was part of the business delegation accompanying the president.  

"The new plants in Vietnam will not only be an expansion of production capacity, but an investment with a purpose: to generate value for the local economy, create skilled jobs, and contribute to food security throughout Southeast Asia," said Renato Costa, the CEO for Friboi, JBS' beef division, in the statement. Friboi presents itself as a leader in the beef market in Brazil.

According to the plan announced by JBS, the first facility will be built in Khu công nghiệp Nam Đình Vũ, including a logistics center with storage capacity, covering pre-processing, cutting and packaging activities.

The agreement projects the second factory will be built in the south of Vietnam two years after the first facility starts operations. It will include similar infrastructure, including a logistics center and a processing plant.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Salesforce Signs Definitive Agreement To Acquire Zoomin
BRIEF-Salesforce Signs Definitive Agreement To Acquire Zoomin
Oct 3, 2024
Sept 24 (Reuters) - Salesforce Inc ( CRM ): * SALESFORCE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE ZOOMIN * SALESFORCE ( CRM ): DEAL DOES NOT RESULT IN ANY CHANGE TO CURRENT FINANCIAL GUIDANCE Source text for Eikon: Further company coverage: ...
BRIEF-Envestnet Stockholders Approve Acquisition By Bain Capital
BRIEF-Envestnet Stockholders Approve Acquisition By Bain Capital
Oct 3, 2024
Sept 24 (Reuters) - Envestnet Inc ( ENV ): * ENVESTNET STOCKHOLDERS APPROVE ACQUISITION BY BAIN CAPITAL * ENVESTNET INC ( ENV ) - EXPECTS TO COMPLETE MERGER IN Q4 OF 2024 * ENVESTNET INC ( ENV ) - ABOUT 99.33% OF VOTES REPRESENTED AT SPECIAL MEETING WERE IN FAVOR OF MERGER Source text for Eikon: Further company coverage: ...
BRIEF-American Healthcare REIT Acquires Remaining Minority Membership Interest in Trilogy REIT Holdings
BRIEF-American Healthcare REIT Acquires Remaining Minority Membership Interest in Trilogy REIT Holdings
Oct 3, 2024
Sept 24 (Reuters) - American Healthcare REIT Inc ( AHR ) : * AMERICAN HEALTHCARE REIT ACQUIRES REMAINING MINORITY MEMBERSHIP INTEREST IN TRILOGY REIT HOLDINGS; BECOMES SOLE OWNER OF TRILOGY REIT HOLDINGS * AMERICAN HEALTHCARE REIT INC ( AHR ) - ACQUISITION PRICE APPROXIMATELY $258 MILLION * AMERICAN HEALTHCARE REIT INC ( AHR ) - ACQUISITION FUNDED BY EQUITY OFFERING...
BRIEF-Trinity Biotech Acquires Metabolomics Diagnostics
BRIEF-Trinity Biotech Acquires Metabolomics Diagnostics
Oct 3, 2024
Sept 24 (Reuters) - Trinity Biotech PLC ( TRIB ): * TRINITY BIOTECH ANNOUNCES ACQUISITION OF METABOLOMICS DIAGNOSTICS TO GROW PRESENCE IN MATERNAL HEALTH MARKET * TRINITY BIOTECH PLC ( TRIB ) - DEAL VALUES METABOLOMICS DIAGNOSTICS AT $1.3 MILLION * TRINITY BIOTECH PLC ( TRIB ) - PREPSIA TEST TO BE COMMERCIALIZED IN U.S. IN 2025 * TRINITY BIOTECH...
Copyright 2023-2026 - www.financetom.com All Rights Reserved